CBA Canada
CBA Canada is the Canada Chapter of Chinese Biopharmaceutical Association, USA (CBA-USA). CBA-Canada is a Canadian federal government-registered non-profit corporation. The headquarter of CBA Canada is located in Montreal, the second largest city in Canada. The primary mission of CBA Canada is to work with CBA-USA to create a platform for easier collaboration and effective communications in the field of life sciences and the biopharmaceutical industry between China, US and Canada.
CBA-USA is one of the largest Chinese American professional associations in the US. Founded in 1995, CBA is an independent, non-political, not-for-profit professional organization, with more than 8,000 members, of which over 80% have Ph.D. degrees. Many internationally renowned scientists including Nobel laureates, business leaders, and high-ranking US and Chinese government officials have attended and spoken at CBA’s annual conferences. CBA’s events and members have been covered by a number of prestigious scientific journals, business magazines, and news media such as Nature, Science, Thomson Reuters, China Central Television (CCTV), PR Newswire, BioPortfolio, and Bioprocess International.
CBA-USA is headquartered in the Greater Washington area, which is the US’s leading biotech cluster. Many of CBA’s members work at renowned institutions, research facilities, biotech/pharmaceutical companies, and top universities in the world, including the FDA, National Institutes of Health, AstraZeneca/MedImmune, GlaxoSmithKline, Johns Hopkins University, George Washington University, Georgetown University, and University of Maryland.
Learn more about the CBA Canada Team>>
CBA Boston Chapter
We are dedicated to provide a platform for our members and partners to:
- Advance scientific discovery in BioPharmaceutical sector
- Broaden professional network and knowledge
- Collaborate to grow their careers and business
Learn more about the Boston Chapter>>
CBA Guangzhou Office
Since 1996 when CBA’s founders led the first team to organize lectures and symposiums in Guangzhou, CBA and the Guangzhou Provincial Government had established strong and long-term friendship and partnership. Then in 2012, CBA’s leadership team visited Guangzhou with a special plan to discuss with the local government, regarding the official establishment of CBA’s branch in China, hoping to help attract overseas projects, talents, investments and IPRs into Guangzhou Economic Development Zone. In July 2013, CBA’s very first office in China – CBA-Guangzhou Office -, was officially founded on the Guangzhou International Bio-Island, with the goal to serve as a bridge between the U.S. and Chinese biomedical companies and professionals, and work as a platform for international technology imports, talent imports and project evaluation. The opening ceremony was held on July 23rd, 2013 in Guangzhou.
The CBA Guangzhou Office was sponsored by the Guangzhou Nanotides Pharmaceuticals Co., Ltd. Its mission is to advance “Nanotech for Peptides” by structure-based functional peptide screening and nanoparticle-enhanced delivery. Its major goal is to commercialize peptides for drug delivery immediately and to develop novel polypeptide therapeutics for pulmonary fibrosis, diabetes mellitus, and NSCLC in the future.
CBA Tianjin Office
The CBA Tianjin Office was founded in September 2016 at the Tianjin Economic and Technological Development Area. It aims to serve as the platform to bring advanced bio-technologies and professional biopharmaceutical talents from US to China, and to promote biomedical collaborations between US and the Northeastern China.
The CBA Tianjin Office is sponsored by the Tianjin CanSino Biotechnology Inc. (CanSino), and the office set-up received generous support from the Tianjin Municipal Government, Tianjin Office of Overseas Chinese Affairs, and many other local government agencies and organizations.
The Tianjin CanSino Biotechnology Inc. is a biotechnology company dedicated to R&D, manufacturing and commercialization of vaccine products for human use. CanSino’s mission is to develop high value and high quality vaccines for China and other emerging countries at an affordable cost.
CBA Shanghai Office
The CBA Shanghai Office was established in September 2016, located in the Caohejing Pujiang Science Park, Minhang District ofShanghai. Its main focus is to serve the CBA individual and corporate members in China and facilitate the business communications and cooperation between the biopharmaceutical industries in US and China, esp. those in the Eastern China regions. The Shanghai Office also aims to expand CBA’s exposure and impacts in China mainland, and to attract more Chinese members into CBA.
CBA Shanghai office is sponsored by Shanghai Furen Medicine R&D Co., Ltd., a leading research and development company focusing on new therapeutics and new medical technologies. Its parent company, the Furen Medicines Group Co., Ltd., is one of the top 100 pharmaceutical companies in China. Shanghai Furen is supporting many top innovation-driven R&D companies by offering initial and follow-up fundings as well as its world-class research and development facilities via five platforms, including cell therapies, antibody and protein therapeutics, new CNS drugs, generics and other healthcare products. The strategic partnership between CBA and Shanghai Furen will not only benefit both parties, but more importantly, promote deeper and further collaborations among many bio-med research institutes and biopharmaceutical companies in the US and China.
Learn more about CBA China Offices>>
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.